MedTrace Logo

HFNC Treatment in COVID-19 Pneumonia

NCT04424836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2020-07-16

No results posted yet for this study

Summary

coronavirus disease 2019 related pneumonia is causing acute respiratory failure and this is the most common reason for ICU admission. We have several different way for respiratory support. HFNC is one of the new technics for oxygen support. Our main purpose to observe the effect of HFNC on coronavirus disease 2019 patients' ICU stay and mortality.

Conditions

  • Coronavirus Infection
  • Pneumonia, Viral
  • Acute Respiratory Failure

Interventions

DEVICE

high flow nasal cannula device

device is supplying oxygen with heated and humidified air in a high flow rate

Sponsors & Collaborators

  • Sisli Hamidiye Etfal Training and Research Hospital

    lead OTHER

Principal Investigators

  • ayse su cinar

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2020-06-04
Completion
2020-06-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04424836 on ClinicalTrials.gov